Submitted by Anonymous (not verified) on 20 August 2026 - 14:37
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 27, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 27, Status: Authorised